Search

everythinglearnresearchcommunity

for

Search:↓

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

5-ARI therapy may help prevent prostate cancer progression.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

Dutasteride works better than finasteride for hair loss, with both being safe to use.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Baricitinib is effective and safe for treating severe alopecia areata.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Efalizumab can cause unexpected excessive hair growth.

New drug dutasteride effectively treats hair loss, but use cautiously due to potential sexual side effects.

Topical bexarotene 1% gel might help regrow hair in alopecia areata and is generally safe.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Ritlecitinib is effective for long-term treatment of severe alopecia areata.

Using 5-alpha reductase inhibitors may increase the risk of mild depression.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

Apremilast did not work for treating severe alopecia areata.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

Baricitinib is effective for severe alopecia areata but has some side effects.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Adding baricitinib will increase costs but offers more treatment options for alopecia areata.

Alitretinoin may help treat mild to moderate alopecia areata.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.